A modern multi-omics data exploration experience with Panomicon.

Rodolfo S Allendes Osorio, Yuji Kosugi, Johan T Nyström-Persson, Kenji Mizuguchi, Yayoi Natsume-Kitatani

Abstract read

In one paragraph

Article in Bioinformatics advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rodolfo S Allendes OsorioPremium Research Institute for Human Metaverse Medicine (WPI-PRIMe), Osaka University, Suita, Osaka 565-0871, Japan.ORCID https://orcid.org/0000-0002-9627-9338

Yuji KosugiLifematics Ltd., Chiyoda ku, Tokyo 101-0051, Japan.

Johan T Nyström-PerssonJNP Solutions, Sumida, Tokyo 130-0015, Japan.

Kenji MizuguchiAI Center for Health and Biomedical Research (ArCHER), National Institutes of Biomedical Innovation, Health and Nutrition, Setsu, Osaka 566-0002, Japan.

Yayoi Natsume-KitataniAI Center for Health and Biomedical Research (ArCHER), National Institutes of Biomedical Innovation, Health and Nutrition, Setsu, Osaka 566-0002, Japan.ORCID https://orcid.org/0000-0003-1749-3318

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: To address the challenges of the storage, sharing, and analysis of multi-omics data, here we introduce the newest version of Panomicon, which includes the improvement of the underlying data model, the introduction of new registration and control access service, together with the seamless integration with other services (like TargetMine for data enrichment analysis), integrated in a completely new, more user friendly web application. Availability and implementation: Panomicon is available online at https://panomicon.nibiohn.go.jp. Unregistered users can access the publicly available data uploaded to Panomicon using the following account: user: guest, password: anonymous. Source code for the application is also freely available under a GNU license at https://github.com/Toxygates/Panomicon/. A brief user guide for the new features of Panomicon is provided as supplementary material online.

Identifiers

PMID39474624

DOI10.1093/bioadv/vbae147

PMCPMC11520228

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.